Unexpected diagnosis of basal cell carcinoma in a patient presenting with a secondary location of Leishmania parasites in the skin

Unexpected diagnosis of basal cell carcinoma in a patient presenting with a secondary location of Leishmania parasites in the skin

Imène Ben Abda^1,2, Rym Ben-Abdallah^1,2,&, Houda Hammami³, Meriem Ben Abid², Hela Mdimagh-Kchir⁴, Karim Bahri⁵, Emna Siala^1,2, Karim Aoun^1,2, Aida Bouratbine^1,2

 

¹Department of Parasitology, Pasteur Institute of Tunis, Tunisia, ²Research Laboratory Medical Parasitology, Biotechnology and Biomolecule LR11IPT-06, University Tunis El-Manar, Pasteur Institute of Tunis, Tunisia, ³Department of Dermatology, Habib Thameur Hospital, Tunis, Tunisia, ⁴Private Laboratory of Pathology, Tunis, Tunisia, ⁵Private Medical office, Infectious Diseases, Tunis, Tunisia

 

 

^&Corresponding author
Rym Ben-Abdallah, Department of Parasitology, Pasteur Institute of Tunis, Tunisia

 

 

 

 

In Tunisia, two clinical forms of Leishmaniasis are endemic [1,2]. Cutaneous leishmaniasis (CL) results in skin lesions at the site of the infective sandfly bite. Visceral leishmaniasis (VL) is a more serious systemic infection associated with high morbidity and not negligible mortality rates. It is characterized by prolonged fever, splenomegaly, pancytopenia and hypergammaglobulinemia [1,3]. Three Leishmania species are responsible of CL cases in Tunisia [2]. Leishmania (L.) major, largely distributed in the centre and the south of country, is the most prevalent with thousands of cases per year [2]. Leishmania infantum and L. tropica are less prevalent and limited mainly to the Northern and the southeastern regions respectively with an incidence of 50-150 cases per year for each [2]. Leishmania infantum is also the single etiological agent of VL in Tunisia. The annual VL incidence does not exceed 50 to 100 cases mainly reported in children under five-years old originating from the northern and central parts of the country [3]. Nevertheless, adult cases, immuno-compromised and even immuno-competent, have been increasingly reported over the last years with a proportion of around 10% of all VL cases [3]. Visceral leishmaniasis due to L. infantum is not generally associated with cutaneous ulcers [1,2]. The occurrence, concomitantly or not, of both CL and VL due to L. infantum is a rarity described in some immuno-compromised patients, notably HIV co-infected [4]. The current report is the first case of a Tunisian immunocompetent adult with both cutaneous and visceral manifestations of leishmaniasis.

 

 

A 74-year-old woman, living in Tunis, Tunisia, was admitted for an investigation of fever evolving since weeks accompanied by sweating and chills. Oral temperature ranging from 38 to 39°C had been regularly measured. She also complained of fatigue, diarrhea, unclear abdominal pain and occasional non-productive cough. Her sole medical history was a well-controlled hypertension. Physical examination was poor, revealing a palpable spleen just below the left costal margin after deep inspiration. A well-circumscribed, erythematous plaque with a thin rolled border and large erosions and crusts on the surface A single well-defined, ulcer surrounded by erythematous edging, with serous oozing (3x3cm in size), was observed at her right arm near the axilla (Figure 1 A). The patient reported that the lesion was painless without tendency to heal, but could not precisely recall when it had first appeared (2 or 3 years). The rest of the physical examination was essentially normal. Otherwise, the patient presented neither risk factors of HIV infection nor chronic disease, transfusion or immunosuppressive therapy. Laboratory findings on admission demonstrated in the blood count a pancytopenia with normocytic normochromic anemia (hemoglobin of 8.7 g/dL), leucocytopenia (2900/mm³) and thrombocytopenia (113000/mm³). Sedimentation rate was 115mm (1^st hour), C-reactive protein 215mg/l and procalcitonine <0.5 ng/ml. Serum Protein Electrophoresis displayed an abnormal pattern with a hypoalbuminemia at 31.1 g/l and a monoclonal hypergammaglobulinemia at 38.4 g/l. Her renal, liver and hemostasis function tests were normal. Chest imaging and cardiac ultrasounds were within normal limits. However, abdomino-pelvic imaging (ultrasound and scan) revealed the presence of a homogenous hepatosplenomegaly. Initially differential diagnosis mainly included brucellosis, typhoid fever, visceral leishmaniasis and hematological malignancies. Bacteriological cultures of blood (3 series), stool and urine revealed all negative. Hepatitis B Virus, Salmonella and Brucella antibody tests were also unrevealing. However, Leishmania rk39 immuno-chromatography test was positive, consistent with a VL diagnosis. A bone marrow aspiration was performed. Its parasitological examination revealed the presence of Leishmania amastigote forms. The patient serum was also positive for Leishmania anti-bodies by immunofluorescence antibody test (titer = 1/400). Blood parasite load determined by a real time quantitative PCR (qPCR) targeting the Leishmania kinetoplast was 400 parasites/ml [5].

 

On another hand, direct microscopic examination performed on skin smears showed no Leishmania amastigotes. However, Leishmania DNA amplification was obtained from the dermal DNA extract, using the same qPCR. Molecular typing of isolates obtained from both samples (blood and skin) was carried out by sequence analysis of ribosomal internal transcribed spacer 1 (ITS1) region of rRNA gene. This analysis showed that the Leishmania strains from the arm cutaneous lesion and the blood corresponded to the species L. infantum and were 100% identical. Visceral Leishmaniasis diagnosis was retained and a course of anti-leishmanial therapy with intravenous amphotericin B deoxycholate at a dose of 1 g/kg/day every 2 days was started. The patient developed a mild renal failure, which was corrected after spacing the cures and rehydration. The response to treatment was rapidly favorable with apyrexia and an improvement in general conditions including resolution of fatigue and increased appetite. The splenomegaly resolved and blood count levels returned to reference ranges. Real-time PCR in blood after 28 days of treatment revealed negative. However, the skin lesion did not improve although Leishmania qPCR on dermal sample became negative. The physician reconsidered CL diagnosis and recommended a skin biopsy which was refused by the patient. A year later, the lesion was clinically almost the same (Figure 1 B). A polarized dermoscopy examination revealed ulcerations and short, fine arborizing vessels (Figure 2), evocative of a basal cell carcinoma. Histopathology examination of the skin lesion biopsy, finally accepted by the patient, confirmed the diagnosis of basal cell carcinoma. A complete excision of the tumor was performed and the evolution was good.

 

 

In classical VL, skin lesions are rare and patients usually do not recall any insect bite or lesion on inoculations' sites [1,3]. The concomitance of cutaneous and visceral syndromes is seen in 2 to 12% of HIV positive cases and mainly as a cutaneous co-morbidity with Kaposi's sarcoma [6]. However this phenomenon is rare among immunocompetent patients as it is reported in this observation [7]. In VL-HIV confection, skin lesions appear as symmetrical hypopigmented macules on the acral surfaces of the extremities or as violacious scaly plaques on the face [6]. These aspects were not observed in our patient (Figure 1 A). Another cutaneous syndrome associated with VL is Post-kala-azar dermal leishmaniasis (PKDL) mainly due to L. donovani in the Indian subcontinent [1]. Skin lesions are diffuse and typically develop after VL therapy, which was also not the case of our patient whose lesions preceded 2 or 3 years VL symptoms' onset. In 1992 Ayadi et al. reported a Tunisian case of unusual simultaneous skin manifestations (3 face-situated nodules) in a 19-month-old girl with VL [8]. However, the parasite was not evidenced in skin biopsies and Leishmania involvement was presumed only on the lesions' improvement after anti-leishmanial therapy. In our patient, DNA parasite detection confirmed the skin location of the parasite which highlights the better sensitivity of real-time PCR compared to smears microscopic examination [5,9].

 

Although VL is mainly a childhood disease in Tunisia, adult cases are not rare. Patients with no immunosuppressive factors, like our patient, are not uncommon and represent around 30% of adult VL cases [3]. Clinical symptoms during adult VL are frequently incomplete and less suggestive in comparison with those observed in infants [1,3]. However, for our patient, apart from the discreet hepatosplenomegaly, clinical and biological parameters were highly suggestive of the disease. The hypothesis that our patient' axilla cutaneous lesion corresponds to a primary CL infection is very unlikely. In fact, such site is not easily accessible to sandflies vectors and is rarely reported during CL surveys [2]. Moreover, the lesion did not heal under anti-leishmanial therapy and was subsequently confirmed as cancer. It corresponds probably to a secondarily colonization by Leishmania amastigotes after the parasite lymphatic or blood spread during the systemic VL infection. The cellular inflammatory environment locally induced by the basal cell carcinoma has certainly favored phagocytosis and local multiplication of the dispersed parasites which explain the positivity of specific qPCR [10]. In addition, ITS PCR-sequencing characterized strains from the 2 locations (blood and skin) as similar corresponding to L. infantum with 100% identity. The negativation of the skin Leishmania qPCR after specific treatment without any improvement of the lesion is a further proof that the cutaneous localization is secondary like a parasite metastasis in an auspicious inflammatory environment represented by the carcinoma [10].

 

 

This report reveals that Leishmania spread during VL can induce secondary location of the parasite in cutaneous sites harboring inflammatory disturbances such as cancers.

 

 

The authors declare no competing interests.

 

 

The contribution of each author is quantified as below: Imène Ben Abda I: management of the case and writing of the manuscript. Rym Ben-Abdallah: diagnosis of the case and writing of the manuscript. Houda Hammami: management of the case and dermoscopy. Meriem Ben-Abid: PCR and sequencing. Hela Mdimagh-Kchir: histopathology. Karim Bahri: management of the case. Emna Siala: biological diagnosis. Karim Aoun: management of the case and revision of the manuscript. Aida Bouratbine: management and diagnosis of the case. All the authors have read and agreed to the final manuscript.

 

 

Figure 1: lesion aspect before (A) and after leishmania specific treatment (B)

Figure 2: ulcerations and short, fine arborizing vessels on dermoscopy

 

 

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18. PubMed | Google Scholar


2. Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21(14):1-9. PubMed | Google Scholar


3. Aoun K, Jeddi F, Amri F, Ghrab J, Bouratbine A. Current epidemiological data on visceral leishmaniasis in Tunisia. Med Mal Infect. 2009;39(10):775-9. PubMed | Google Scholar


4. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97 Suppl 1:3-15. PubMed | Google Scholar


5. Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42(11):5249-55. PubMed | Google Scholar


6. Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol. 2003;97 Suppl 1:107-14. PubMed | Google Scholar


7. Ben-Ami R, Schnur LF, Golan Y, Jaffe CL, Mardi T, Zeltser D. Cutaneous involvement in a rare case of adult visceral leishmaniasis acquired in Israel. J Infect. 2002;44(3):181-4. PubMed | Google Scholar


8. Ayadi A, Loukil M, Lakhoua R, Boubaker S, Debbabi A, Ben Rachid SB et al. Case report of skin manifestations in infantile Mediterranean kala-azar. Ann Pediatr. 1992;39(4):265-7. PubMed | Google Scholar


9. Jara M, Adaui V, Valencia BM, Martinez D, Alba M, Castrillon C et al. Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol. 2013;51(6):1826-33. PubMed | Google Scholar


10. Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, Falagas ME. Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg. 2007;101(12):1181-9. PubMed | Google Scholar